Showing results (1071-1080 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|October 30, 2024
Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteriaSara Faye Borenstein, Ruth Eliahou, Alexandra Amiel, et al.
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Neuro-Oncology Advances|August 30, 2024
Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastomaSamuel A Goldlust, Samuel Singer, Lori A Cappello, et al.
Neuro-Oncology Advances|August 19, 2024
Intraoperative mapping of epileptogenic foci and tumor infiltration in neuro-oncology patients with epilepsyDongqing Sun, Eline V Schaft, Bibi M van Stempvoort, et al.
Neuro-Oncology Advances|December 26, 2022
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literatureGabrielle Arbour, Benjamin Ellezam, Alexander G Weil, et al.
Neuro-Oncology Advances|December 8, 2022
Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phaseLauro N Avalos, Tracy L Luks, Tyler Gleason, et al.
Neuro-Oncology Advances|June 18, 2021
Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assayStephen Shuford, Lindsay Lipinski, Ajay Abad, et al.
Neuro-Oncology Advances|July 21, 2021
Single-cell image analysis reveals a protective role for microglia in glioblastomaZoe Woolf, Molly E V Swanson, Leon C Smyth, et al.
Neuro-Oncology Advances|June 25, 2021
Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patientsElisa Izquierdo, Paula Proszek, Giulia Pericoli, et al.
Pageof 135